Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Conservative Treatment × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1

Conditions

Interventions

Cyclophosphamide 87 Doxorubicin 80 Radiotherapy 76 Temozolomide 63 Filgrastim 48 Ifosfamide 47 Bevacizumab 47 Etoposide 42 Imatinib Mesylate 39 Gemcitabine 37 Vincristine 35 pembrolizumab 30 pazopanib 28 Irinotecan 28 Methotrexate 26 fludarabine phosphate 25 Peripheral Blood Stem Cell Transplantation 25 Carboplatin 25 Nivolumab 24 Trabectedin 23 Melphalan 23 Paclitaxel 22 Magnetic Resonance Spectroscopy 22 Docetaxel 22 Cisplatin 22 Busulfan 22 Sirolimus 20 Rituximab 19 Mycophenolic Acid 18 Antilymphocyte Serum 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022159 2025-06-05

HYPOSARC

Institut Claudius Regaud

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡